Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis

Published:2016-03-15 Issue:9 Volume:43 Page:994-1003
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Singh S.¹²³,Heien H. C.⁴,Sangaralingham L. R.⁴,Schilz S. R.⁴,Kappelman M. D.⁵,Shah N. D.⁴⁶⁷,Loftus E. V.¹

Affiliation:

1. Division of Gastroenterology and Hepatology; Mayo Clinic; Rochester MN USA

2. Division of Gastroenterology; University of California San Diego; La Jolla CA USA

3. Division of Biomedical Informatics; University of California San Diego; La Jolla CA USA

4. Robert D and Patricia E Kern Center for the Science of Health Care Delivery; Mayo Clinic; Rochester MN USA

5. Division of Pediatric Gastroenterology and Hepatology; University of North Carolina; Chapel Hill NC USA

6. Division of Health Care Policy and Research; Mayo Clinic; Rochester MN USA

7. Optum Labs; Cambridge MA USA

Funder

U.S. National Library of Medicine

Janssen Biotech

AbbVie

UCB Pharma

American College of Gastroenterology

National Center for Advancing Translational Sciences

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13580/fullpdf

Reference15 articles.

1. Tumor necrosis factor inhibitors for inflammatory bowel disease;Nielsen;N Engl J Med,2013

2. Clinical pharmacokinetics of TNF antagonists: how do they differ?;Nestorov;Semin Arthritis Rheum,2005

3. Optum labs: building a novel node in the learning health care system;Wallace;Health Aff (Millwood),2014

4. Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada;Benchimol;J Clin Epidemiol,2014

5. Colectomy and the incidence of postsurgical complications among ulcerative colitis patients with private health insurance in the United States;Loftus;Am J Gastroenterol,2008

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Infliximab Versus Adalimumab in Adult Subjects With Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis;Cureus;2024-06-02

2. Treatment of Inflammatory Bowel Disease with Biologics in Japan: A Single-Center, Retrospective Pharmacoeconomic Study;Biological and Pharmaceutical Bulletin;2024-01-20

3. Drug utilization of biologic therapy in Crohn’s disease and ulcerative colitis: a population-based Danish cohort study 2015–2020;Scandinavian Journal of Gastroenterology;2023-02-21

4. Comparison of Long-Term Outcomes of Infliximab and Adalimumab Therapy in Biologic-Naive Patients with Ulcerative Colitis;2023-02-14

5. Continuous clinical remission with biologics in ulcerative colitis: the ‘AURORA’ comparison study;European Journal of Gastroenterology & Hepatology;2022-09-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3